Literature DB >> 10719238

Age-associated decline in gamma-glutamylcysteine synthetase gene expression in rats.

R Liu1, J Choi.   

Abstract

Although glutathione (GSH) concentration has been reported to diminish with age, the mechanism underlying such age-associated decline in the GSH content is not well understood. In this study, we compared the gene expression of both subunits of gamma-glutamylcysteine synthetase (GCS), the rate-limiting enzyme in de novo GSH synthesis, in young, adult, and old Fisher 344 rats. It was found that GCS activity was significantly decreased with increased age in liver, kidney, lung, and red blood cells (RBC). Parallel with the decreased enzyme activity, the protein and mRNA contents of both GCS subunits also changed inversely with age in liver, kidney, and lung, implying a decreased GCS gene expression during aging. Such a reduced GCS gene expression was accompanied by a decline in total GSH content without any change in cysteine concentration. Furthermore, the decreased GCS gene expression in old rats was not associated with a decline in the plasma insulin or cortisol level. This study showed, for the first time, that the expression of both GCS subunit genes was decreased in some organs of old rats, which would result in a reduced rate of GSH biosynthesis. Such decline in GSH synthetic capacity may underlie the observed decrease in GSH content during aging.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719238     DOI: 10.1016/s0891-5849(99)00269-5

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  40 in total

1.  Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments.

Authors:  Hongqiao Zhang; Honglei Liu; Kelvin J A Davies; Constantinos Sioutas; Caleb E Finch; Todd E Morgan; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease.

Authors:  Cheng Zhang; Cynthia Rodriguez; James Spaulding; Tak Yee Aw; June Feng
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Effects of age and caloric intake on glutathione redox state in different brain regions of C57BL/6 and DBA/2 mice.

Authors:  Igor Rebrin; Michael J Forster; Rajindar S Sohal
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

Review 4.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.

Authors:  Olayemi Joseph Olajide; Nnaemeka Tobechukwu Asogwa; Blessing Oluwapelumi Moses; Christiana Bidemi Oyegbola
Journal:  Metab Brain Dis       Date:  2017-04-13       Impact factor: 3.584

Review 6.  Elevation of glutathione as a therapeutic strategy in Alzheimer disease.

Authors:  Chava B Pocernich; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2011-10-12

7.  Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.

Authors:  R-M Liu; T van Groen; A Katre; D Cao; I Kadisha; C Ballinger; L Wang; S L Carroll; L Li
Journal:  Neurobiol Aging       Date:  2009-07-14       Impact factor: 4.673

8.  Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin.

Authors:  Pamela Maher
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

9.  Aging impairs the expression of the catalytic subunit of glutamate cysteine ligase in soleus muscle under stress.

Authors:  Chiao-Nan Joyce Chen; Holly M Brown-Borg; Sharlene G Rakoczy; Deborah A Ferrington; LaDora V Thompson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-12-16       Impact factor: 6.053

10.  Transient glutathione depletion determines terminal differentiation in HL-60 cells.

Authors:  Suzanne M Krance; Peter C Keng; James Palis; Nazzareno Ballatori
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.